01—Abstract
Summary
Summary of the 8-K filed May 27, 2025. Cited figures are marked; the original filing is the authoritative source.
Tenet Healthcare Corporation reported the final voting results from its 2025 Annual Meeting of Shareholders, held on May 22, 2025, as disclosed under Item 5.07 of this Form 8-K.
Shareholders elected all 13 nominated directors, each to serve until the next annual meeting or until a successor is duly elected or qualified. Each director received more FOR votes than AGAINST votes, with the lowest FOR total at 75,129,573 (Saumya Sutaria) and the highest AGAINST total at 3,175,124 for the same nominee. Broker non-votes were 7,527,011 for each director.
Shareholders approved, on an advisory basis, the company's executive compensation, with 72,929,010 votes FOR and 5,362,708 AGAINST. They also ratified Deloitte & Touche LLP as the independent registered public accountants for the year ending December 31, 2025, with 85,288,950 votes FOR and 538,057 AGAINST.
A shareholder proposal requesting a report on strategies and programs for improving maternal health outcomes did not pass. It received 3,845,664 FOR votes against 73,121,521 AGAINST, with 1,379,137 abstentions and 7,527,011 broker non-votes.
02—Key points
Key Highlights
- The 2025 Annual Meeting of Shareholders was held on May 22, 2025.
- All 13 nominated directors were elected, including Saumya Sutaria, J. Robert Kerrey, Vineeta Agarwala, James L. Bierman, Roy Blunt, Richard W. Fisher, Meghan M. FitzGerald, Cecil D. Haney, Christopher S. Lynch, Richard J. Mark, Tammy Romo, Stephen H. Rusckowski, and Nadja Y. West.
- Executive compensation was approved on an advisory basis, with 72,929,010 votes FOR and 5,362,708 AGAINST.
- Deloitte & Touche LLP was ratified as independent registered public accountants for the year ending December 31, 2025, with 85,288,950 votes FOR and 538,057 AGAINST.
- A shareholder proposal on a report on strategies and programs for improving maternal health outcomes did not pass, receiving 3,845,664 FOR and 73,121,521 AGAINST.
- Broker non-votes were 7,527,011 on each director election and on the executive compensation vote.
- Tammy Romo received 2,335,099 AGAINST votes, the second-highest AGAINST total among directors after Saumya Sutaria's 3,175,124.
03—Questions
Frequently Asked Questions
When and where was Tenet Healthcare's 2025 Annual Meeting held?
The 2025 Annual Meeting of Shareholders was held on May 22, 2025, as reported in this Form 8-K filed May 27, 2025.
Were all director nominees elected?
Yes. Shareholders elected all 13 directors listed in the filing. Each received more FOR votes than AGAINST votes. Saumya Sutaria had the lowest FOR total at 75,129,573 and the highest AGAINST total at 3,175,124.
How did shareholders vote on executive compensation?
Shareholders approved the company's executive compensation on an advisory basis, with 72,929,010 votes FOR, 5,362,708 AGAINST, and 54,604 ABSTAIN, plus 7,527,011 broker non-votes.
Was the auditor selection approved?
Yes. Shareholders ratified Deloitte & Touche LLP as independent registered public accountants for the year ending December 31, 2025, with 85,288,950 votes FOR, 538,057 AGAINST, and 46,326 ABSTAIN.
What shareholder proposal was voted on, and did it pass?
A shareholder proposal requesting a report on strategies and programs for improving maternal health outcomes did not pass. It received 3,845,664 FOR, 73,121,521 AGAINST, and 1,379,137 ABSTAIN votes, with 7,527,011 broker non-votes.
04—Continue